Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
brexanalone
clinical data
clinical study
data
depression
disease
enzyme
gag
gene editing
genome editing
hunter syndrome
ids
jeff jonas
major depressive disorder
mental illness
mps ii
mucopolysaccharidosis ii
neuroscience
phase 3 trial
postpartum depression
psychiatric disorders
sage therapeutics
san francisco
san francisco blog main
san francisco top stories
sandy macrae
sangamo therapeutics
studies
zinc finger nucleases
What
phase
2
×
therapeutics
2
×
trial
2
×
approval
benefit
brexanalone
depression
drug
editing
fda
gene
going
hits
hour
humans
infusion
isn't
landmark
little
mark
medical
medicine
morning
nasdaq
postpartum
ppd
reported
reports
results
sage
sangamo
soon
stock
study
supervised
surges
u.s
win
Language
Current search:
therapeutics
×
trial
×
phase
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
